Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Shore

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
Urologic Oncology|September 22, 2020
Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancerAlicia K Morgans, Neal Shore, Diane Cope, et al.
The Journal of Urology|May 2, 2019
Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder CancerMaxwell V Meng, Jürgen E Gschwend, Neal Shore, et al.
The Canadian Journal of Urology|February 18, 2014
Prospective multi-center study elucidating patient experience after prostatic urethral liftNeal Shore, Sheldon Freedman, Steven Gange, et al.
Urology Practice|August 30, 2023
Influencing Best Practices for Genomic and Germline Testing in UrologyNeal Shore, Takara A Scott, Abhishek Srivastava, et al.
Urology|November 3, 2024
Evaluating the Importance of Practice-level Factors on Adherence to Prostate Cancer Treatment Guidelines in UrologyNeal Shore, Gordon Brown, Benjamin Lowentritt, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder CancerLawrence Karsh, Neal Shore, Mark Soloway, et al.
Journal of Clinical Anesthesia|June 5, 2010
Safety evaluation of fospropofol for sedation during minor surgical proceduresTong J Gan, Bradley D Berry, Evan F Ekman, et al.
BJUI Compass|October 21, 2022
Functional impact of androgen-targeted therapy on patients with castration-resistant prostate cancerTomasz M Beer, Neal Shore, Alicia Morgans, et al.
The Journal of Urology|April 5, 2021
Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate CancerSusan Halabi, Shan Jiang, Emi Terasawa, et al.
Journal of Managed Care & Specialty Pharmacy|May 28, 2024
Within-trial hospitalization resource utilization and budget impact analysis for darolutamide in metastatic hormone-sensitive prostate cancer using ARASENSAlicia K Morgans, Jamie Partridge Grossman, Noman Paracha, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Urologic Oncology|September 22, 2020
Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancerAlicia K Morgans, Neal Shore, Diane Cope, et al.
The Journal of Urology|May 2, 2019
Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder CancerMaxwell V Meng, Jürgen E Gschwend, Neal Shore, et al.
The Canadian Journal of Urology|February 18, 2014
Prospective multi-center study elucidating patient experience after prostatic urethral liftNeal Shore, Sheldon Freedman, Steven Gange, et al.
Urology Practice|August 30, 2023
Influencing Best Practices for Genomic and Germline Testing in UrologyNeal Shore, Takara A Scott, Abhishek Srivastava, et al.
Urology|November 3, 2024
Evaluating the Importance of Practice-level Factors on Adherence to Prostate Cancer Treatment Guidelines in UrologyNeal Shore, Gordon Brown, Benjamin Lowentritt, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder CancerLawrence Karsh, Neal Shore, Mark Soloway, et al.
Journal of Clinical Anesthesia|June 5, 2010
Safety evaluation of fospropofol for sedation during minor surgical proceduresTong J Gan, Bradley D Berry, Evan F Ekman, et al.
BJUI Compass|October 21, 2022
Functional impact of androgen-targeted therapy on patients with castration-resistant prostate cancerTomasz M Beer, Neal Shore, Alicia Morgans, et al.
The Journal of Urology|April 5, 2021
Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate CancerSusan Halabi, Shan Jiang, Emi Terasawa, et al.
Journal of Managed Care & Specialty Pharmacy|May 28, 2024
Within-trial hospitalization resource utilization and budget impact analysis for darolutamide in metastatic hormone-sensitive prostate cancer using ARASENSAlicia K Morgans, Jamie Partridge Grossman, Noman Paracha, et al.
Pageof 20